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Abstract 
Purpose: To formulate and evaluate pH-sensitive controlled release cefixime microspheres based on 
crosslinked chitosan and acryl amide-grafted-poly ethylene glycol  
Method: pH sensitive interpenetrating network (IPN) cefixime microspheres based on chitosan, its 
grafted copolymer, and hydrolyzed grafted copolymer were prepared by precipitation and crosslinking 
methods. The formulations were characterized by Fourier transform infrared spectroscopy (FTIR),X-ray 
diffraction(XRD),Differential scanning calorimetry (DSC), Scanning electron microscopy(SEM),Raman 
spectroscopy for particle size analysis. Swelling ratio, Effect of drug loading on encapsulation efficiency 
was investigated. FTIR, SEM, DSC, X-ray diffraction XRD,  swelling studies were investigated for 
controlled drug release of drug at pH 2 and pH 7.4. 
Results: The microspheres were spherical in shape with a narrow particle size distribution (56 – 124 
µm) and encapsulation efficiency of up to 93 %. The % swelling ratio for blend microspheres of C-PEG 
are higher than that of plain chitosan in both pH.  In both the pH media release was much faster in plain 
Chitosan microspheres. For instance, only 83% drug was released at 11.5 h for C-grafted copolymer 50 
in pH 7.4 media compared to 41% drug released in pH 2 media for the same time whereas 80% drug 
was released at 11.5 h for C-grafted copolymer 50 (hydrolyzed) in pH 7.4 media compared to 38% drug 
released in pH 2. Drug release followed Higuchi release kinetics. FTIR, DSC, XRD data indicate that 
there was no interaction between the drug and the polymers used. 
Conclusion: It is evident from this study that chitosan microspheres could be further developed to 
serve as an effective biodegradable carrier for controlled release of cefixime. 
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Chitosan is the generic name of a linear random 
copolymer of β-(1-4) linked –D-glucosamine 
whose molecular structure comprises a linear 
backbone linked through glycosidic bonds. The 
basic amine groups of this polysaccharide are 
protonated and thus positively charged in most 
physiological fluids. Chitosan is mostly 
hydrophilic and the percentage of acetylated 
monomers and their distribution in the chains has 
a critical effect on its solubility and conformation 
in aqueous media. Hence, chitosan exhibits pH-
dependent behavior in solution and some 
interesting biopharmaceutical properties such as 
muco-adhesiveness, ability to open, and 
epithelial tight junction. These characteristics of 
chitosan have attracted many scientists working 
in the biomedical field, particularly drug delivery 
[1-4]. Due to its unique polymeric cationic 
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character, chitosan-based gels and films have 
been extensively examined in the pharmaceutical 
industry for its potential in the development of 
drug delivery system [5].    
 
In recent years, much attention has been given 
to the development of interpenetrating polymeric 
network (IPN) from natural biodegradable and 
biocompatible polymeric materials [6]. Chitosan 
is biopolymer with immense structural 
possibilities for chemical and mechanical 
modification to generate novel properties [7]. 
Among many methods of modifying the original 
structures of polymers, graft copolymerization is 
an easier method, which makes the derived 
polymer as attractive biomaterials in controlled 
released application [8]. Grafting of polar 
monomers onto chitosan by Graft 
copolymerization improves solubility which 
enhances its adsorption capacity [8,9]. 
 
Several reagents have been used for the 
crosslinking of chitosan, including glutardehyde, 
genipin, ethylene glycol, diglycidylether and 
diisavanate [9,10]. Although the grafting of 
chitosan modifies its properties, it is possible to 
retain some interesting characteristics such as 
mucoadhesivity, biocompatibility and 
biodegradability [11-12]. Besides, chitosan being 
a linear polysaccharide has been found to be a 
good chemical entity for preparing microspheres 
because of its high crosslinking ability due to the 
presence of amino (-NH2) groups. A good 
number of approaches to improve the wet 
strength of hydrogels and IPN polymeric network 
of chitosan have been reported elsewhere [13].   
Cefixime is an oral third generation 
cephalosporin antibiotic. It possess anti-
bactericidal activity and used in the treatment of 
gonorrhea, tonsillitis and pharyngitis. Its 
biological half-life is of 3 -4 h. Cefixime has pka 
value of 2.5 and being a weak acid is insoluble in 
water after its oral administration which results 
into the poor bioavailability. Around 40-50% is 
excreted through renal and biliary route. In order 
to improve the therapeutic effect of the drug by 
increasing its bioavailability the IPNs of chitosan 
with acrylamide-grafted –PEG and hydrolysized 
acrylamide-grafted PEG microspheres was 
synthesized for controlled release of Cefixime in 
both acidic and basic media. 
 
To the best of our knowledge no work has been 
done so for by using this drug. The present work 
deals with the in vitro release of loaded 







Cefixime USP was obtained as a gift from 
Kosher Pharmaceuticals, India. High molecular 
weight chitosan poly(D-glucosamine) was 
purchased from Sigma–Aldrich, Belgium; acryl 
amide was purchased from Qualigens Mumbai, 
India; while polyethylene glycol 4000, 
hydrochloric acid, glutaradehyde, acetic acid and 
sodium hydroxide were purchased from SD Fine 
Chemicals, India. All other chemicals used in this 
work were of analytical reagent grade 
                                                                                                                   
Synthesis of polyethylene glycol grafted–
acryl amide 
 
Polyethylene glycol 4000 was dissolved in water 
at 60 - 65 oC and treated with acryl amide under 
nitrogen gas atmosphere followed by addition of 
trace quantity of potassium persulfate under 
continuous stirring at a temperature of 65 oC for 
5 h [14]. The resulting product was washed with 
water: methanol (1:1 v/v), filtered and kept in 
vacuum for drying at 60 oC. About 2 wt % 
(100ml) solution of PEG-grafted acryl amide was 
hydrolyzed using 50 ml of equimolar 
concentration of sodium hydroxide solution at 60 
oC for 5 h. The final product was filtered and 




Approximately 2 g of the polymer blend obtained 
above was dissolved in 2 % acetic acid 
containing a required amount of Cefixime 
(100mg) and was dispersed with equal quantities 
of light liquid paraffin stirred at high speed and 
the resulting water-oil emulsion was stabilized by 
addition of 1 % Tween 80 solution. Thereafter, 
the aqueous phase of the emulsion was 
hardened to form a microgel. Glutaraldehyde 
(5ml) was added drop-wise to the emulsion and 
stirred for 30 min at room temperature to stabilize 
the prepared microsphere. The mixture was then 
left to cool at 10-15oC for 30 min. The 
microspheres were collected by filtration using 
Whatman-41 filter paper (pore size: 25µm). 
Finally, the microspheres were washed with 30ml 
of hexane and water to remove paraffin oil, acid, 
water and excess glutaraldehyde. In order to 
determine the drug release characteristics of the 
microgels, the formulation was prepared by 
varying amount of drug and blend ratio of 
chitosan with PEG, PEG-grafted copolymer as 
well as hydrolyzed PEG-grafted copolymer 
matrices. Drug concentration with different  
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Table 1: Encapsulation efficiency and equilibrium swelling of Cefixime formulation 
 





   Encapsulation        Particle                   pH 2           pH 7.4 
efficiency (%)*        size (µm)* 
C-50 50 76.42±0.2 56 ± 0.2             19619   196   185 
C-100 100 79.02±0.8 76.3±0.5 201 190 
C-PEG-50 50 83.96±0.4 89.9±0.4 226 245 
C-PEG-100 100 85.06±0.1 103±0.4 239 258 
C-grafted copolymer   50 50 87.03±0.3 105±0.2 248 265 
C-grafted copolymer  100 100 89.28±0.5 113±0.2 256 270 
C-grafted copolymer   50 
(hydrolyzed) 
50 91.04±0.2 119±0.5 261 273 
C-grafted copolymer-100 
(hydrolyzed) 
C-grafted copolymer-100    
(hydrolyzed)-(2.5GA)                                
C-grafted copolymer-100    
(hydrolyzed)-(5.0G A)                                
C-grafted copolymer-100    
(hydrolyzed)-(7.5GA)        
            100 
 
            100     
 
            100 
 
            100 
 
     93.01±0.9 
 
      90.4±0.5 
 
      85.9±0.2 
 





114±0.1      
 
















SD = standard deviation; *mean ± SD (n = 3); GA = glutaraldehyde crosslinked; C = chitosan.  
Drug concentrations used were 50 mg and 100 mg in each formulation. 
 
polymeric blend and their formulation codes are 
given in Table 1. 
 
Fourier transform infrared spectroscopy 
(FTIR)  
The FTIR spectra of Cefixime and drug-loaded 
microspheres were recorded on an FTIR system 
(JASCO-4100, Japan) using KBr disc with a 
scanning range of 4000 - 400 cm-1 in order to 
assess structural changes that could have 
occurred in the drug due to drug-polymer 
interaction following microsphere formation. 
 
Evaluation of water content and swelling ratio 
of microspheres 
 
The microsphere formulations (beads) (~ 50 mg)  
were placed in 50 mL distilled water and at 30 
min intervals, beads were taken out and excess 
water was removed using filter paper and 
weighed immediately on an electronic weighing 
balance (Model AUY220, Shimadzu, Japan). 
Swelling ratio was expressed as % weight gain. 
 
X-ray diffraction (XRD) studies 
 
X-ray diffraction (XRD) studies (Bruker D8 
Advance diffractometer, Germany, CuKά 
radiation, Nickel filter) were performed to 
determine crystalline patterns of the drug in the 
cross-linked polymer network. The XRD patterns 
of pure cefixime, drug-loaded chitosan 
microspheres matrix and blank microspheres 




Differential scanning calorimetry (DSC) 
 
DSC thermograms of the pure drug and IPN 
microsphere were recorded with a differential 
scanning calorimeter (DSC Q1000V9.4 Build 
287) from 0-400 oC at a heating rate of 10°C/min. 
 
Particle size  
 
The particles size of the microsphere was 
measured by Raman spectrometer (Lesser 536 
Aglitron USA) equipped with camera-microscope 
system. The test sample was spread flat on a 
glass microscope slide and the experiment was 
performed at room temperature at a 
magnification of 100x200 µm slit width and 
exposure time of 5 sec. Triplicate tests were 
carried out for all samples.  
 
Scanning electron microscopy (SEM) studies 
 
The surface and cross sectional morphologies of 
the microspheres were examined using high 
resolution scanning electron microscopy (FEI 
Quanta FEG 200).  
 
Drug release studies 
 
In vitro drug release studies were performed 
using USP paddle single stage digital apparatus 
with 900 ml of phosphate buffer (pH 7.4) and 
HCl/KCl buffer (pH 2) as dissolution medium. At 
predetermined time intervals, 5 ml samples each 
were withdrawn from the medium at various time 
intervals and the medium replenished 
immediately with the same volume of fresh 
dissolution medium to maintain sink conditions. 
The amount of dissolved drug in the sample 
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taken was measured (after filtration through 
Whatman-41 filter paper (pore size: 25µm) 
spectrophotometrically (model-V-670PC, Jasco 
UV-visible-NIR spectrophotometer) at a λmax of 
288 nm.  
 
Moreover  all the four release kinetics model 
namely, zero order kinetics, first order kinetics, 
Korsenmeyer Peppas model and Higuchi model 
were applied to Data obtained from in vitro 
release studies. It was observed that zero order 
kinetics model showed a r2 value of 0.7453 
(~0.7182-0.8012); first order kinetics model with 
r2 value of 0.8660 (~ 0.8120-0.8710); Higuchi 
model with r2 value of 0.990 (~ 0.980-.0.990) and 
Korsenmeyer peppas model with r2 value of 
0.9215 (~ 0.9210-0.9219). The assessment of 
the release kinetics revealed that drug release 
from the chitosan microspheres followed Higuchi 
model. The mechanism of drug release from 
microspheres was diffusion controlled. Data 
obtained from in vitro release studies were fitted 
to Higuchi model (Q = Kt½) to find out the 
mechanism of drug release from the chitosan 
microsphere. The tests were carried out in 
triplicate .  
 
Determination of drug content 
 
A sample (100 mg) of the formulation was 
weighed accurately, transferred quantatively into 
a 100 mL volumetric flask and diluted up to mark 
using distilled water. The mixture was stirred 
overnight to allow total release of the drug from 
the microspheres. After filtration through 
Whatman-41 filter paper (poresize:25µm) the 
filtrate was assayed spectrophotometrically at 
264 nm.  
                                                 
Statistical analysis 
 
Statistical analysis was performed using Origin 
7.0 software. All the tests were run in triplicate 
and the data were analyzed by one-way ANOVA 
for drug release. Statistical significance was set 






The FTIR spectra of plain PEG, PEG-grafted 
copolymer and hydrolyzed PEG-grafted 
copolymer are shown in Figure 1. The broad 
band appearing at 3495.09 cm-1 corresponds to 
the associated –OH stretching vibrations of the 
hydroxyl group of the grafted copolymer (Fig 1a-
A). A new peak appeared at 3071.24 cm-1 and 
the related peak at 1632.35cm-1 corresponds to –
NH bending vibrations of the primary amides of 
acryl amide. In the spectra of hydrolyzed PEG-
grafted copolymer, the shoulder peak (at 856 cm-
1) disappeared but two new peaks appeared 
around 1330 cm-1 and 1091cm-1, respecrively, 
which are due to the anti-symmetric vibrations of 
-COOH groups. 
 
The FTIR spectrum of plain chitosan showed two 
peaks around 836 and 1020 cm-1 corresponding 
to saccharin structure in the spectra (Fig 1b-A). 
The observed sharp peaks at 1385 and 1650 cm-
1 are assigned to -CH3 group (Fig 1b-B). Due to 
increase in peak intensity at ~1594 cm-1, there 
are two distinguishing peaks at ~1398 and ~ 
1475cm-1. The spectrum of chitosan blend with 
acrylamide grafted with PEG hydrolyzed complex 
was observed at around 1638 cm-1 and 
corresponds to –NH3+ group due to protonation of 
the primary amino group in the presence of the 
carboxylic group of the hydrolyzed polymer (Fig 
1b-C). The peak at ~1428 cm-1 confirms the 
presence of carboxylic acid in the polymer. 
 
Swelling of microgels 
 
In plain chitosan microspheres in pH 2 media, % 
equilibrium swelling of microspheres is higher 
than the value of it in pH 7.4. Swelling increased 
from 185-190% in pH 7.4 media compared to 
swelling in pH 2 media which increased about 
196-201%. The % equilibrium swelling for blend 
microsphere of chitosan and PEG are higher 
than plain chitosan microspheres, formulations of 
C-PEG-50 to C-PEG-100. The % equilibrium 
swelling of C-grafted copolymer 50 to C-grafted 
copolymer 100 increased to 245-258% in pH 7.4 
and 226-239% in pH 2 respectively. The % 
equilibrium swelling of formulations containing C-
grafted copolymer 50 (hydrolyzed) to C-grafted 
copolymer 100 (hydrolyzed) increased to 273-
283% in pH 7.4 and to 261-271% in pH 2.  
 
 
Fig 1: FTIR spectra of hydrolyzed PEG-g–copolymer 
(1a A), PEG-g–copolymer (1a B), plain PEG ((1a C) 
pure chitosan (1b A), chitosan/acrylamide grafted with 
PEG (1b B), and chitosan/acrylamide grafted with 
PEG after hydrolysis (1b C) 
 
X-ray diffraction (XRD) 
 
XRD aids in assessing changes in the 
crystallinity of a drug after formulation or 
processing. As indicated in Fig 2 b, cefixime 
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showed characteristic intense peaks at 10 and 30 
o due to its crystalline nature. However, these 
peaks were not seen in the drug-loaded matrix 
complex, placebo microgels and drug-loaded 
microgels which indicates that the encapsulated 
drug became amorphous. 
 
Differential scanning calorimetry (DSC) 
thermograms 
 
DSC is a useful tool that could assist in 
determining if any changes have taken place in 
the drug itself and the drug matrix. Figure 2b-A 
indicates that the thermogram of the pure drug 
exhibited an endothermic peak at 202 oC, 
corresponding to its melting point, but this peak 
was absent from the thermogram of the drug-
loaded microspheres which suggests that most 
of the drug was well dispersed within the matrix.  
 
 
Fig 2: XRD diffractogram of pure drug (2a A), drug-
loaded chitosan microspheres (2a B), and blank 
microspheres (2a C); DSC thermograms of pure drug 
(2b A), drug-loaded microspheres (2b B), and blank 




The size of the microsphere was dependent on 
the amount of drug loaded, extents of drug 
loading and degree of crosslinking. All the 
microspheres were spherical with diameter 
ranging from 56 to 124 µm. The size of the 
microspheres increased from 103 to 124 µm for 
100 % drug-loaded chitosan-grafted copolymer 
100 (hydrolyzed). 
 
Drug content and entrapment efficiency 
 
In developing an effective formulation, it is 
important to achieve high encapsulation 
efficiency (EE). In the present case, % EE data 
show a dependence on % drug loading, For 
instance, formulation containing high amount of 
drug exhibited higher value of EE and also % EE 
is higher for chitosan microspheres of blends of 
hydrolyzed grafted copolymer as compared to 
other formulations. The effect of cross linking 
was studied by adding different amount of 
glutaraldehyde ranging from 2.5 mL to 7.5 mL. It 
was observed that increasing amount of 
glutardehyde in the microspheres decreased 
%EE (Table 1).   
 
Scanning electron micrographs (SEM) 
 
SEM microgram indicates that the microspheres 
were fairly spherical in shape and that polymeric 
material surrounded the microspheres (Fig 3A). 
The surface was, however, rough and rugged 
(Fig 3B). The type and blend of polymeric used in 





Fig 3:  SEM images of microspheres showing (A) 
polymeric materials around microspheres and (B) 




The release data for the various formulations are 
shown in Figure 4. In both the pH media release 
was much faster in plain chitosan microspheres. 
For instance, only 83% drug was released at 
11.5 h for C-grafted copolymer 50 in pH 7.4 
media compared to 41% drug released in pH 2 
media for the same time whereas 80% drug was 
released at 11.5 h for C-grafted copolymer 50 
(hydrolyzed) in pH 7.4 media compared to 38% 
drug released in pH 2. On subjecting the drug 
release data to Higuchi model (Q = Kt½) in order 
to ascertain the drug release mechanism, a 
linear relationship was observed with a 
regression coefficient close to 1 (r2 = 0.990). 
 
 
Fig. 4: % Cumulative drug release of microsphere 
formulations loaded with 50 % drug at pH 2 and 7.4 
Key: For pH 7.4, a = C-50, b = C-PEG-50, c = C-
grafted copolymer 50, d = C-grafted copolymer 50 
(hydrolyzed); while for pH 2.0, e = C-50, f = C-PEG-
50, g = C-grafted copolymer 50, h = C-grafted 
copolymer 50 (hydrolyzed) 
 
Shivashankar & Mandal 





The release data for the various formulations are 
shown in Figure 4. At both pH (2.0 and 7.4), drug 
release was considerably faster non-crosslinked 
chitosan microspheres than from crosslinked 
microspheres, with 89.7 and 53.4 % release in 
11.5 h from C-50 at pH 2.0 and 7.4, respectively. 
On the other hand, 35 % drug was released in 
11.5 h for C-grafted copolymer 50 (hydrolyzed) at 
pH 7.4.  On subjecting the release data to the 
Higuchi model in order to ascertain the release 
mechanism, a linear relationship was observed 




Chitosan exhibits a pH-sensitive behavior as a 
weak polybase due to the large number of amino 
groups on its chain. It dissolves easily at low pH 
but is insoluble at high pH. [16].The mechanism 
of pH-sensitive swelling involves protonation of 
the amine groups in chitosan at low pH 
conditions. This protonation leads to chain 
repulation, diffusion of proton and counter ions  
together with water inside gel and dissociation of 
secondary interaction. This property helps in the 
delivery of drugs to the stomach and chitosan 
has been widely investigated as a delivery 
matrix. [17,18].  
 
The carboxylic groups of acryl amide moieties 
are hardly ionized and PEG chains are unable to 
interact with non-ionized carboxylic groups by 
hydrogen bonding. As a result, copolymers 
present a collapsed conformation; on the other 
hand, as the pH value approaches to the pKa 
value and above, carboxylic acid ionization leads 
to the breakage of the hydrogen bonds and the 
number of ionized units increases dramatically. 
The ionization of the carboxylic groups results in 
a repulsive interaction between the PEG chains 
and acrylic acid molecules at high pH.    
    
In case of the swelling-controlled mechanism 
when diffusion of a drug is significantly faster 
than hydrogel distention, swelling is considered 
to be controlling the release behavior [19]. Micro 
gels are hydrophilic in nature and swell 
considerably in phosphate buffer solution. pH–
dependent study suggests that swelling ratio at 
pH 7.4 was higher than that of micro gels at pH 
6. Almost all chitosan was in its ionized form i.e., 
-COOH forms COO- groups which could form 
intermolecular H-Bonding with OH- groups within 
the network during swelling. The polymeric 
complex has been expanded more in size at pH 
7.4 compared to pH 2.0.  
 
Increase in the amount of glutaraldehyde 
incorporated in the matrix lowered encapsulation 
efficience due to reduced free volume space 
available in the polymeric matrix as the 
microsphere became more rigid due to higher 
crosslink density and complexation.  
 
XRD and DSC results indicate that there were no 
interactions between drug, chitosan and other 
ingredients used in preparing the microspheres. 
Thus, it suggests that the prepared microsphere 
would be stable. 
 
Sustained drug release over a period of 12 h was 
achieved by crosslinking chitosan with the 
release data fitting well to the Higuchi model. It 
suggests that the drug released was controlled 
by diffusion mechanism. Uptake of water 
significantly hindered and slowed down drug 
diffusion due to strong electrostatic interactions 
between the polymeric matrix and the drug. 
Chitosan is deprotonated at pH 7.4, leading to 
disruption of the interaction between drug and 
polymeric matrix. The carboxylic groups of 
chitosan become gradually ionized at pH 7.4 
which favors microsphere drug diffusion from the 
microsphere into the surrounding medium [15]. 
Thus, the collapsed polymeric matrix played an 
important role in hindering drug diffusion, 
effectively contributing to sustained release at pH 
7.4. This can be attributed to complexation of the 
amino group of chitosan at this pH, while at pH 2; 




The hydrophilic nature of polyacrylamide-
modified PEG has been successfully utilized to 
develop crosslinked chitosan microspheres. The 
resulting pH-sensitive interpenetrating network of 
the microsphere matrix facilitated sustained 
release of cefixime. Further work, including in 
vivo evaluation, is however, required to ascertain 
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